Abstract
Various factors contribute the development of cardiovascular complications in type 2 diabetes mellitus (DM2): hyperglycemia and components of insulin resistance syndrome, including obesity, dyslipidemia and arterial hypertension. All of them should be considered in therapeutic strategies. In the beginning of 21st century new pharmacological agents were developed leading to the major changes in DM2 treatment. So, an ideal treatment should have not only a glucose-lowering effect, but other (“non-glycemic”) actions affecting multiple coexistent factors. Since the novel classes of antidiabetic drugs with additional favorable pleiotropic effects independent from direct glucose-lowering effect have been introduced, the choice of an appropriate agent has become more complicated and requiresindividual approach and wide knowledge in this area. The present articles reviews various groups of glucose-lowering agents and their effects on blood pressure level in DM2 patients. We believe it will help to make the right individual choice of an antidiabetic agent taking into account its pleiotropic effects.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
